glp 1 weight loss medication michigan When it comes to loss, GLP-1 products are becoming more popular, including here in Upper Michigan. https://www.uppermichiganssource.com/2026/02/10/glp-1-medication-rise-up Michigan obesity trends GLP-1

August 1, 2024: Mounjaro Lawsuit Progresses with Bellwether Trials Set for Late 2025 Proceedings are moving forward in preparations for the bellwether trials set to start at the end of 2025

Tirzepatide (Zepbound) - FDA Approved 2023: According to clinical trials cited by multiple sources including NBC News, tirzepatide (a GIP/GLP-1 dual agonist) showed approximately 21% to 22.5% mean weight loss on its highest dose after 72 weeks, compared to approximately 3% for placebo

This result suggests that the body contains an inherent backup plan," Campbell said

Ojima A, Matsui T, Maeda S, Takeuchi M, Yamagishi S

See Important Safety Information about GLP-1 medications, including Boxed Warning, at ro.co/safety-info/glp1 Contact: [email protected] SOURCE Ro

Clinical trials show that while some weight loss persists after discontinuation, most people regain 5070% of lost weight within one year without ongoing medication or significant lifestyle reinforcement